Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster 08.07.2024 15:09 Fiercebiotech.com Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster ntaylor Mon, 07/08/2024 - 08:09
